Claudia Cagnetti
Overview
Explore the profile of Claudia Cagnetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
989
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lattanzi S, Meletti S, Trinka E, Brigo F, Turcato G, Rinaldi C, et al.
J Clin Med
. 2023 Jun;
12(11).
PMID: 37297805
Background: The study aimed to develop a model and build a nomogram to predict the probability of drug resistance in people with post-stroke epilepsy (PSE). Methods: Subjects with epilepsy secondary...
2.
Papiri G, Puca E, Marcucci M, Paci C, Cagnetti C
Cureus
. 2022 Nov;
14(10):e30480.
PMID: 36415395
Anti-leucine-rich glioma-inactivated protein 1 (anti-LGI1) encephalitis is a rare autoimmune disorder, classified within limbic encephalitides, and characterized by seizures and subacute cognitive-behavioral impairment, mainly affecting short-term memory and usually involving...
3.
Gasparini S, Neri S, Brigo F, Cianci V, Mammi A, Pascarella A, et al.
Neurol Sci
. 2022 May;
43(9):5229-5236.
PMID: 35639217
Background: Identifying late epileptic seizures (LS) following cerebral venous thrombosis (CVT) can be useful for prognosis and management. We systematically reviewed the literature to identify risk factors for LS due...
4.
Lattanzi S, Trinka E, Turcato G, Rinaldi C, Cagnetti C, Foschi N, et al.
Eur J Neurol
. 2022 May;
29(8):2481-2485.
PMID: 35582937
Background And Purpose: The progressive nature of epileptogenesis raises the question of whether the latent period may already carry information about the characteristics of the subsequent epilepsy. This study aimed...
5.
Lattanzi S, Cagnetti C, Foschi N, Ciuffini R, Osanni E, Chiesa V, et al.
Drugs Aging
. 2021 Jun;
38(7):603-610.
PMID: 34075567
Background: Clinical data regarding use of newer antiseizure medications (ASMs) in an older population are limited. In randomized-controlled, placebo-controlled trials, older patients are under-represented, and protocols deviate markedly from routine...
6.
Lattanzi S, Rinaldi C, Cagnetti C, Foschi N, Norata D, Broggi S, et al.
Brain Sci
. 2021 Apr;
11(4).
PMID: 33810310
Objectives: The study aimed to explore the clinical predictors of pharmaco-resistance in patients with post-stroke epilepsy (PSE). Methods: Patients with epilepsy secondary to cerebral infarct or spontaneous intracerebral hemorrhage were...
7.
Lattanzi S, Coccia M, Pulcini A, Cagnetti C, Galli F, Villani L, et al.
Sci Rep
. 2020 Oct;
10(1):18524.
PMID: 33116220
The impact of reperfusion therapies on cognition has been poorly explored and little knowledge exists. We explored the influence of endovascular treatment (EVT) on cognitive outcome in patients with anterior...
8.
Lattanzi S, Logullo F, Cagnetti C, Di Bella P, Silvestrini M
Mult Scler Relat Disord
. 2020 Mar;
37:101373.
PMID: 32172989
No abstract available.
9.
Lattanzi S, Carbonari L, Pagliariccio G, Cagnetti C, Luzzi S, Bartolini M, et al.
J Neurol Sci
. 2019 Sep;
405:116435.
PMID: 31487558
Purpose: High-grade carotid stenosis can affect cognition, but the relationship between stenosis correction and cognitive outcome is not fully understood, yet. The aim of this study was to evaluate the...
10.
Lattanzi S, Brigo F, Trinka E, Zaccara G, Cagnetti C, Del Giovane C, et al.
Drugs
. 2018 Nov;
78(17):1791-1804.
PMID: 30390221
Background: Approximately one-third of patients with epilepsy presents seizures despite adequate treatment. Hence, there is the need to search for new therapeutic options. Cannabidiol (CBD) is a major chemical component...